Explore expert perspectives, actionable strategies, and industry updates shaping the future of medical aesthetics.
Evolus Receives Warning Letter From FDA Due to Problematic Instagram Reel
The FDA issued an untitled letter to Evolus on September 28 regarding an Instagram reel promoting Jeuveau, the company’s tox offering, as reported by Fierce Pharma. The agency cited two main violations: Evolus was given 15 working days to respond. The warning challenges Evolus’ long-held corporate strategy of branding Jeuveau strictly as an “edgy” consumer…
Proposed Federal Legislation Aims to Restrict Corporate Practice of Medicine and MSO Control
Introduced on September 16, 2026, H.R. 10444 (the Stop Corporate Takeovers of Physicians Act of 2026) is a proposed federal bill that would establish strict corporate practice of medicine (CPOM) regulations and limit the control Management Services Organizations (MSOs) hold over medical practices, including med spas and aesthetic clinics. A recent blog post from SpaKinect…
2026 UK Aesthetic Consumers Prefer Regenerative Treatments Over Quick Fixes
The UK aesthetic industry experienced an 8% growth in 2026, driven by a major cultural shift away from dramatic, “quick-fix” alterations toward subtle, regenerative, and natural-looking skin health according to a recent article posted on Who What Wear. Drawing insights from leading London aesthetic experts—Eleanor Hartley (Hart Medical) and Dr. Ahmed El Muntasar (The Aesthetics…
Allergan Launches AA Signature Consultation Tools with SKIN360
Allergan Aesthetics launched AA Signature™ in the U.S., debuting with its first assessment protocol, AA Signature: SKIN360. Grounded in research showing that 96% of patients want comprehensive assessments and 80% proceed with multi-product treatments following one, the initiative equips healthcare providers with structured, multimodal consultation tools. The initial SKIN360 protocol targets skin smoothness and hydration,…
FDA Updates Kybella Label: Off-Label Risks Explained
The FDA has updated the prescription labeling for Kybella (deoxycholic acid) to include new warnings regarding serious risks from off-label use and persistent injection-site reactions. Summary of Key Updates
Enhancing Patient Care: Addressing Menopause in Aesthetic Practices
A new survey released this week by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) highlights a sharp rise in women connecting menopause and perimenopause to facial aging. Key takeaways include: Why This Matters to You For medical spas and aesthetic practices, this trend marks a pivotal opportunity. By asking thoughtful questions about…
New BELOTERO® Fillers: FDA-Approved HA Innovations from Merz
Merz Aesthetics is expanding its U.S. BELOTERO® portfolio with the FDA approval of two new biomimetic hyaluronic acid (HA) dermal fillers: BELOTERO VOLUME® (+) and BELOTERO INTENSE® (+). Engineered using patented Cohesive Polydensified Matrix (CPM®) gel technology, these fillers integrate seamlessly into skin tissue to support facial balancing, natural expressions, and authentic movement. Key Additions…
Allergan Aesthetics Releases Layered Beauty: The New Aesthetic Mindset Report
Allergan Aesthetics, an AbbVie company, recently released its Layered Beauty: The New Aesthetic Mindset report based on insights from 12,000 beauty-involved consumers across nine global markets alongside expert medical practitioner perspectives. The report highlights a global shift in aesthetic medicine away from one-time, drastic transformations and toward long-term, personalized, and holistic care. Key findings emphasize…
The Rise of Regenerative Aesthetics: High Consumer Interest Meets Evolving Science
The term “regenerative aesthetics” has gained popularity, incorporating various biological therapies like PRP and exosomes. Despite only 37% consumer familiarity, interest in treatments is high due to desires for natural results and prevention of aging. However, experts caution that excitement is outpacing scientific evidence, especially for newer treatments.
2025 Trends in Cosmetic Surgery: Natural Restoration on the Rise
The ASPS 2025 Procedural Statistics Report highlights a trend toward natural restoration in cosmetic procedures, with a 7% increase in surgical and 6% in reconstructive procedures. Non-surgical treatments dominate, and facial fat grafting grew by 39%. Older adults show the highest demand, with significant requests related to GLP-1 weight-loss drugs.
Something went wrong. Please refresh the page and/or try again.